Canine Genetics Model for Human Health

Canine Genetics: A Powerful Model for Human and Dog Health

Two Belgian herding breeds face a significantly higher risk of developing gastric cancer, a disease with striking similarities to a common and lethal human cancer. A new study from Cornell University, Utrecht University, and the NIH has identified 15 specific genetic locations linked to this predisposition, offering a rare window into the disease’s complex genetic origins. This research underscores how specific dog breeds serve as powerful models for understanding genetic disease in all species.

Belgian Breeds Reveal a Complex Genetic Architecture for Cancer

Gastric cancer is the fifth most common cancer in humans, with poor survival rates and limited treatments. Its genetic causes are poorly understood. Researchers led by Cook SR and Evans JM at Cornell found a naturally occurring model in dogs: Belgian Tervuren and Belgian Sheepdogs. These breeds disproportionately develop intestinal and diffuse tumor subtypes that are clinically and histologically similar to the human disease. Using a Bayesian genome-wide association study, the team identified 15 genomic loci associated with the cancer. Notably, a closely related breed, the Belgian Malinois, rarely develops the disease despite sharing much of its ancestry.

The analysis went beyond simple association. Variant filtering revealed specific germline mutations likely driving risk. These include regulatory variants affecting the EPAS1 and PTEN genes, both known cancer players, and a coding variant in CD101. Intriguingly, two loci were specifically overrepresented in dogs with the intestinal tumor subtype. Perhaps most compelling was the discovery of what appears to be natural genetic protection in the Malinois. Across-breed comparisons showed Malinois are enriched with specific haplotypes at the SOX2-OT and IGF2BP2 genes, and these genetic patterns are found at a much higher frequency in healthy control dogs from the at-risk breeds.

Protective Haplotypes and a Key Risk Gene: HDAC2

The comparison between the at-risk Tervuren/Sheepdogs and the resistant Malinois proved highly informative. While Malinois carry protective versions of SOX2-OT and IGF2BP2, the high-risk breeds commonly possess putative regulatory variants for the HDAC2 gene. HDAC2 is a histone deacetylase, a type of enzyme that modifies how DNA is packaged and can silence tumor-suppressor genes. Its presence at a high frequency and its association with cancer risk in the study suggests it is a major contributor to the breed’s predisposition.

This research describes a “complex genetic architecture,” meaning risk is not controlled by one gene but by the combined effect of many, some increasing risk and others potentially modifying it. The study also identified new candidate genes like PDZRN3 and KLHL29 that have not been previously associated with human gastric cancer, opening fresh avenues for investigation in human oncology. The dog model, with its streamlined genetics due to selective breeding, effectively cuts through the noise to highlight these key genetic players.

The Promise and Challenge of Polygenic Risk Scores for Pets

A separate review by Momen M and Muir P in the American Journal of Veterinary Research examines the translation of this type of genetic discovery into clinical tools. Polygenic Risk Scores (PRSs) aggregate the small effects of many genetic variants across the genome to predict an individual’s genetic liability for a complex disease. In human medicine, PRSs are becoming valuable for conditions like heart disease and diabetes. For dogs and cats, the potential is significant but fraught with hurdles.

The authors note that companion animal research suffers from smaller sample sizes and limited genomic resources compared to human studies. More critically, the genetic heterogeneity across dog breeds is a double-edged sword. While it creates clear breed predispositions, it also means that a PRS developed in one breed often fails to translate to another. Breed-specific variants and unique genetic architectures require tailored prediction models. The Belgian gastric cancer study exemplifies this: the risk and protective alleles are likely highly specific to that family of breeds. Developing a universal canine gastric cancer PRS would be difficult, but creating a breed-specific test for Tervuren and Sheepdogs is a direct and practical application of this work.

From Genetic Discovery to Clinical Action for Breeders and Owners

For owners of Belgian Tervuren and Sheepdogs, this research provides a scientific basis for heightened vigilance. Veterinarians of these patients should be aware of the breed’s specific predisposition. While the study does not yet recommend a specific commercial test, it lays the foundation for developing one. In the future, genetic screening for the key risk variants like those in HDAC2 could identify higher-risk individuals within the breed, warranting more proactive gastrointestinal health monitoring.

For the broader canine community, this work reinforces a critical concept: breed is not just about appearance, but about health probability. Responsible breeding programs could use such genetic data to gradually reduce the frequency of high-risk alleles, as is done with other genetic disorders. For pet owners, understanding a breed’s predispositions—from gastric issues in Belgians to periodontal disease in small breeds or other genetic risks—is key to preventive care. It allows for tailored wellness plans, such as specific screening ages or dietary considerations, potentially catching serious conditions earlier when intervention is more effective. The ultimate beneficiaries are both dogs and humans, as these canine models continue to clarify the murky genetics of shared diseases.

Frequently Asked Questions

Should I get my Belgian Tervuren tested for these genetic variants?

Currently, there is no commercially available genetic test directly from this study. However, the research provides a strong rationale for future test development. Owners of these breeds should discuss the breed’s known risk with their veterinarian to establish an appropriate monitoring plan.

Does this mean my Belgian Malinois is completely safe from gastric cancer?

The study found the Malinois breed carries protective genetic haplotypes and has a markedly lower disease frequency, but it does not guarantee complete immunity. Any dog can develop cancer, but the genetic risk for Malinois is significantly lower than for their Tervuren and Sheepdog relatives.

Can this research help human patients with gastric cancer?

Yes. The canine model identified 15 risk loci, including genes like PDZRN3 and KLHL29 not previously linked to human gastric cancer. This provides new biological pathways for scientists to investigate, which could lead to novel diagnostics or therapeutic targets for humans.

Are Polygeneic Risk Scores available for common dog diseases now?

Widespread, clinically validated PRSs for dogs are not yet a reality, primarily due to the need for large, breed-specific studies and the genetic complexity between breeds. The review by Momen and Muir frames this as a major opportunity for future veterinary research.

Sources:
https://pubmed.ncbi.nlm.nih.gov/40445765/
https://pubmed.ncbi.nlm.nih.gov/40081319/
https://pubmed.ncbi.nlm.nih.gov/40043055/